We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

116 hedge funds and large institutions have $66.6M invested in Sanofi Contingent Value Rights in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

1% more funds holding

Funds holding: 115 → 116 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital invested

Capital invested by funds: $74M → $66.6M (-$7.42M)

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
3.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
14
Reduced
21
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Elliott Management
New York
+$7.32M
2
MCM
Moore Capital Management
New York
+$685K
3
DAM
Deltec Asset Management
New York
+$598K
4
PWAM
Park West Asset Management
California
+$423K
5
CPA
Columbia Pacific Advisors
Washington
+$164K

Top Sellers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
-$12.9M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$4.09M
3
LCM
Lonestar Capital Management
California
-$1.24M
4
CCA
Catalyst Capital Advisors
New York
-$203K
5
Millennium Management
Millennium Management
New York
-$142K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Whitebox Advisors
Minnesota
$14.1M +$6.92K +10,000 +0%
EM
2
Elliott Management
New York
$13.4M +$7.32M +10,581,000 +123%
MCM
3
Mason Capital Management
New York
$10.3M – – –
CPM
4
Chesapeake Partners Management
Maryland
$5.84M – – –
OAM
5
Oxford Asset Management
United Kingdom
$3.51M – – –
GCM
6
Gruss Capital Management
New York
$2.8M – – –
COPPSERS
7
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.22M – – –
CL
8
CSS LLC
Illinois
$1.84M +$42.1K +60,836 +2%
Citigroup
9
Citigroup
New York
$1.09M -$42 -61 -0%
Brown Advisory
10
Brown Advisory
Maryland
$991K -$2.45K -3,536 -0.2%
MFP
11
Michael F. Price
$893K – – –
UOC
12
UBS O'Connor
Illinois
$848K – – –
Millennium Management
13
Millennium Management
New York
$784K -$142K -205,300 -15%
DAM
14
Deltec Asset Management
New York
$777K +$598K +865,056 +352%
CLOS
15
Compagnie Lombard Odier SCmA
Switzerland
$700K – – –
MCM
16
Moore Capital Management
New York
$693K +$685K +990,200 New
PC
17
Pomelo Capital
New York
$490K – – –
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$430K – – –
PWAM
19
Park West Asset Management
California
$428K +$423K +611,903 New
GF
20
Gabelli Funds
New York
$350K -$4.29K -6,198 -1%
ACM
21
Akanthos Capital Management
California
$350K – – –
Bank of America
22
Bank of America
North Carolina
$336K -$1.34K -1,939 -0.4%
BMO
23
Beck Mack & Oliver
New York
$333K -$25.1K -36,312 -7%
FCM
24
Farmstead Capital Management
New Jersey
$322K – – –
TA
25
Teton Advisors
New York
$280K – – –
1
2 3 4 5

GCVRZ Hedge Fund Activity: Q2 2015 in Review

116 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2015, worth a combined $66.6M — down 10% from $74M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GCVRZ positions and 11 closed out — a net gain of 4 holders — while 14 added to existing stakes and 21 trimmed.

The largest buyer was Elliott Management, adding an estimated $7.32M. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $12.9M sold.

  • 116 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2015, up from 115 in Q1 2015.
  • Funds reported $66.6M of Sanofi Contingent Value Rights stock for Q2 2015, down 10% quarter-over-quarter.
  • 15 funds opened new Sanofi Contingent Value Rights positions in Q2 2015 and 11 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2015 was Elliott Management, an estimated $7.32M added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2015 was Fir Tree Capital Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2015.